Upside, a housing stability platform partnering with health insurers, announced Thursday that it raised $20 million in Series A funding. The company’s AI-powered platform helps payers and employers ...

The AMA and 61 healthcare organizations are urging Congress to advance four Medicare reforms to stabilize physician payments ...

Blackstone Life Sciences is placing a bet on Pfizer’s berobenatide, a GLP-1 drug designed for monthly dosing. This GLP-1 drug comes from Metsera, which Pfizer acquired last year in a $10 billion deal.

The race to develop new obesity drugs is playing out with measures of how much and how quickly patients shed weight. Raj Kannan, CEO of startup Alveus Therapeutics, sees the field shaping up as a ...

Bayer’s asundexian, brand name Sunharbo, is the first FDA-approved drug in a new class cardiovascular medicines Approval of ...

Blocking proteins that drive inflammation is a tried and true way of treating immunological disorders, but Lycia Therapeutics contends its approach of eliminating these proteins could be better. The ...

Medical Microinstruments (MMI) has raised $125 million in Series D financing to expand the reach of its Symani Surgical ...

Oura has delayed its IPO, citing market uncertainty, but the consumer wearables company is not exactly sitting around twiddling its thumbs. On Tuesday, the San Francisco company announced it is ...

Maven Clinic is making its virtual care services accessible through more than 475 health plans nationwide. Maven Clinic, a virtual clinic for women and families, announced on Wednesday that its ...

Nkarta will present initial clinical data for its natural killer cell therapy in two disorders, myositis and systemic ...

Typically, software placed on the market will undergo changes and updates after its initial release. In the case of ...

One question on everyone’s mind is what the impact of the midterm elections will be on the US healthcare system in the near ...